The effect of stress on the expression of the amyloid precursor protein in rat brain  by Sayer, Rachel et al.
AA
A
P
t
f
l
A
t
©
K
T
f
T
m
n
s
l
c
a
r
t
o
l
C
2
0
dAvailable online at www.sciencedirect.com
Neuroscience Letters  431 (2008) 197–200
The effect of stress on the expression of the amyloid
precursor protein in rat brain
Rachel Sayer 1, Deborah Robertson 2, David J.K. Balfour,
Kieran C. Breen 3, Caroline A. Stewart ∗
Alzheimer’s Disease Research Centre, Section of Psychiatry and Behavioural Sciences, Division of Pathology and Neuroscience,
University of Dundee, Ninewells Hospital & Medical School, Dundee DD1 9SY, UK
Received 13 July 2007; received in revised form 17 October 2007; accepted 14 November 2007
bstract
The abnormal processing of the amyloid precursor protein (APP) is a pivotal event in the development of the unique pathology that defines
lzheimer’s disease (AD). Stress, and the associated increase in corticosteroids, appear to accelerate brain ageing and may increase vulnerability to
lzheimer’s disease via altered APP processing. In this study, rats were repeatedly exposed to an unavoidable stressor, an open elevated platform.
revious studies in this laboratory have shown that a single exposure produces a marked increase in plasma corticosterone levels but animals develop
olerance to this effect between 10 and 20 daily sessions. Twenty-four hours after stress, there was an increase in the ratio of the deglycosylated
orm of APP in the particulate fraction of the brain, which subsequently habituated after 20 days. The levels of soluble APP (APPs) tended to be
ower in the stress groups compared to controls except for a significant increase in the hippocampus after 20 days of platform exposure. Since
PPs is reported to have neurotrophic properties, this increased release may represent a neuroprotective response to repeated stress. It is possible
hat the ability to mount this response decreases with age thus increasing the vulnerability to stress-induced AD-related pathology.
 2007 Elsevier Ireland Ltd. 
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he role of amyloid precursor protein (APP), or its processed
ragments, in normal brain function is not well understood.
here is a significant body of evidence to suggest that the
embrane-bound protein plays a role in cell–cell interaction,
euronal plasticity and the formation and the consolidation of
ynaptic connections [9]. Soluble APP (APPs) generated fol-
owing cleavage by the-secretase enzyme is thought to promote
ell survival, neurite outgrowth and synaptogenesis [15]. The
dministration of APPs in vivo can reduce the level of neu-
onal damage following traumatic brain injury [23] and increase
he number of EGF-responsive progenitor cells [6]. Lower levels
f APPs in rats were associated with poor performance in the
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atermaze [1] whereas intracerebroventricular administration
f sAPP enhanced the performance of mice in various learning
asks [17]. However if membrane-bound APP is cleaved by the
- and -secretase protease enzymes it generates the A pep-
ide that aggregates to form the neuritic plaques which define
lzheimer’s disease pathology [9].
For a majority of AD cases it is not known what causes
he shift to the amyloidogenic pathway although there is some
reclinical and clinical evidence to suggest that stress may
xacerbate the progression of AD and may be associated with
he pathological hallmarks of the condition. In animals, expo-
ure to isolation stress accelerated the age-dependent deposition
f amyloid plaques in the Tg2576 mouse model of AD [11].
hronic immobilisation stress had a similar effect on both
emory impairment and amyloid deposition within the hip-
ocampus and cortex of the APPV7171-CT100 mouse model
13]. These effects may be a direct consequence of the corti-
osteroids released during the response to stress as prolonged
xposure to high levels of these hormones appears to accelerate
ge-related decrements in neuronal morphology and function
19]. Studies on patients with AD have shown that hypercorti-
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days stress group had a significantly increased proportion of deg-
lycosylated APP relative to control (p < 0.05). Close inspection
of the data (Fig. 2B) suggests that the APP band ratio was still
increased above control levels in the frontal cortex after 20 days98 R. Sayer et al. / Neuroscien
olism is associated with greater cognitive deficits [25] and that
ncreased plasma cortisol is associated with greater decline in
oth clinical and cognitive measures of dementia severity [10].
The aim of this study was to determine whether exposure
o acute and repeated stress affected the levels of the two pri-
ary forms of APP in the normal rat brain and whether this was
egionally selective.
Male Sprague Dawley rats (Harlan, UK) weighing between
50 and 300 g were maintained on a 12:12 h light:dark cycle with
ights on at 6.00 a.m. and access to food and water ad libitum.
fter 1 week they were divided into 4 treatment groups (n = 5
ats per group): a 20 days stress group, a 10 days stress group,
n acute stress group (1 day) and a control group. Stress expo-
ure involved placing the rats on an open elevated platform for
0 min. Acutely this procedure reliably increases the levels of
orticosteroid hormones in the blood [2] but this response habit-
ates after between 10 and 20 days exposure [18,22]. Control
nimals were not exposed to the stressor but were taken to the
ame laboratory and handled in an equivalent manner. All exper-
mental procedures were subjected to local ethical review and
overed by a U.K. Home Office project licence (PPL 60/2845).
Rats were killed 24 h after the last stress exposure or handling
ession to measure the effect of stress-induced genomic changes
n APP. Brains were removed and the frontal cortex, parietal cor-
ex, striatum and hippocampus were dissected on ice and stored
t −80 ◦C prior to analysis. The pathological changes that char-
cterise Alzheimer’s disease first appear in the cortical regions of
he brain and the hippocampus. The striatum was included as an
rea also rich in cholinergic neurones that remains relatively free
f pathology until advanced stages of the disease. The brain sam-
les were then homogenised (10% w/v) in homogenising buffer
1 mM EDTA, 1 mM EGTA, 0.32 M sucrose, 1 mM Tris, pH 8.0
ontaining protease inhibitor cocktail) at 4 ◦C. Homogenates
ere centrifuged at 100,000 × g for 60 min at 4 ◦C and the
esulting supernatant, containing the soluble brain fraction, was
liquoted into 1 ml fractions and stored at −20 ◦C. The pellet
as resuspended in 1% (v/v) Triton X-100 and re-centrifuged at
00,000 × g for 60 min at 4 ◦C. The supernatant, containing the
embrane, mitochondrial and nuclear fractions, was stored at
20 ◦C in 1.0 ml aliquots while the triton-insoluble pellet was
iscarded.
The total protein concentration of each sample was deter-
ined spectrophotometrically using the method of Bradford
4] and APP expression determined in 25 ug protein samples
y Western blot analysis using a monoclonal primary anti-
ody (MAB348 clone 22C11 Calibochem 1:1500) [16]. This
ecognises an N-terminal epitope (AA66-81) that is common to
oth APP and the amyloid precursor-like protein 2 (APLP2).
he autoradiographs were scanned and band densities calcu-
ated using the SCION image (v3) software package. In order
o determine whether there were any regional differences in
PP expression between the groups the data were analysed by
epeated measures analysis of variance using stress exposure as
he between subject factor (GROUP) and brain region as the
ithin subject factor (REGION). Post-hoc analysis of signifi-
ant effects was carried out using one-way ANOVA or Dunnett
-tests where appropriate.
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In the soluble brain fractions APPs was detected as a single
and with a molecular weight of approximately 128 kDa (Fig. 1).
he global analysis revealed that there was a significant effect of
ROUP (F[3, 16] = 3.79, p < 0.05) and a significant interaction
etween GROUP and REGION (F[9, 48] = 3.58, p < 0.005) sug-
esting that stress had a regionally selective effect on the level of
PPs. Subsequent analysis of this interaction revealed that this
as due to the significant increase in APPs in the hippocampal
egion only following 20 days of stress (p < 0.05).
In the particulate brain fractions, APP was detected as a dou-
let with molecular weights of approximately 128 and 121 kDa
Fig. 2A). Global analysis of total APP revealed a significant
ffect of GROUP (F[3, 16] = 8.02, p < 0.005) but no interac-
ion between GROUP and REGION suggesting that stress had
nfluenced the level of APP but that this was not a region-
lly selective effect. Post-hoc testing confirmed that all stress
roups expressed a significantly greater level of APP pro-
ein in the particulate brain fractions compared to controls
p < 0.05). Therefore, although the pattern appeared to be dif-
erent in the parietal cortex compared to other regions, this
ffect was not large enough to influence the overall statistical
nalysis.
The 121 kDa molecular weight protein band has previously
een demonstrated to represent the deglycosylated form of the
rotein [16]. When this band was expressed as a percentage
f total APP (Fig. 2B) global analysis confirmed a significant
ffect of GROUP (F[3, 16] = 11.6, p < 0.001) but again no inter-
ction between GROUP and REGION suggesting that stress had
ffected the APP band ratio but not in a regionally selective way.
ost-hoc testing confirmed that, overall, only the acute and 10ig. 1. APP protein expression in soluble brain fractions. Striatum (STR), hip-
ocampus (HPC), frontal cortex (FCX) and parietal cortex (PCX) generated from
ontrol rats and rats exposed to the elevated platform for 1 day (acute), 10 and
0 days. Values represent mean ± S.E.M. (n = 5 in each group). Representative
lots are shown with the molecular weight of the protein bands indicated.
R. Sayer et al. / Neuroscienc
Fig. 2. APP protein expression in particulate brain fractions. Striatum (STR),
hippocampus (HPC), frontal cortex (FCX) and parietal cortex (PCX) generated
from control rats and rats stressed on an elevated platform for 1 day (acute), 10
and 20 days. (A) Total APP protein expression in the particulate brain fractions.
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AB) The lower molecular weight band of the particulate form of APP (121 kDa)
xpressed as a percentage of total particulate APP levels. Representative blots
re shown with the molecular weights of the protein bands indicated.
tress but this effect did not significantly influence the global
nalysis.
Although stress exposure appears to have altered the pro-
essing of APP with changes in the glycosylation patterns of the
articulate form and the levels of APPs, it is not clear whether
his is due to changes in the release of corticosterone over this
ime period [18,22] or if it is due to the action of other neu-
otransmitters, such as acetylcholine, that are altered following
tress [14]. Other studies have shown that directly treating rats
ith the glucocorticoid agonist dexamethasone can also increase
articulate APP levels in the rat cortex, cerebellum and brain
tem without significant changes in APPs [5]. However, hip-
ocampal APP expression was not specifically reported in that
tudy. In this study, stress significantly elevated the proportion
f deglycosylated APP in particulate brain samples for up to
0 days but after 20 days there was no significant difference
rom control. This follows the previously published pattern of
abituation of the plasma corticosterone response in rats treated
ith exactly the same protocol [18,22]. Corticosteroids havelso been shown to control the process of protein glycosyla-
ion and in the hippocampus sialyltranferase activity appears to
e highly regulated by aldosterone [8]. The expression of the
ineralocorticoid receptor, which has a relatively high affinity
D
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or aldosterone, is dynamically altered in the dorsal hippocam-
us during 20 days exposure to the elevated platform [18]. The
tress-induced increase in the particulate deglycosylated form
f the protein may therefore be a consequence of corticosteroid
eceptor changes. Although statistically, there was no signifi-
ant difference between the ratio of deglycosylated to total APP
n the hippocampus compared to other brain regions, this was
he area that demonstrated the greatest change following acute
xposure and was the only one where the ratio fell below control
evels after 20 days of stress (Fig. 2B).
The hippocampus was also the only area where the amount
f APPs increased following repeated stress. The hippocam-
us is involved in terminating the corticosteroid response to
tress [20] and may also be important in habituating to repeated
tress as previous studies have shown that 20 days exposure
o the elevated platform produces a selective increase in GR
mmunoreactivity in the dorsal hippocampus [18]. The increase
n APPs most likely represents an increase in soluble APPs
hat has been shown to exhibit neurotrophic properties. Since
he hippocampus it also an area of the brain thought to be cru-
ial for the formation of certain types of memory, the changes
n APPs may have consequences for cognitive function. Previ-
us studies have shown that stress can impair memory [21] or
nder certain circumstances can enhance it [3]. In particular,
epeated exposure to the elevated platform has been shown to
mprove spatial memory using a watermaze task in young rats
ut only if they have been previously exposed to the apparatus
26].
The increase in deglycosylated APP seen following one or 10
ays stress exposure may indicate an increased risk of A forma-
ion as the deglycosylated form of the protein is less likely to be
rafficked to the cell membrane [16] for cleavage by -secretase
ut rather may be retained in the endoplasmic reticulum/golgi.
ince -secretase appears to be localised to the golgi and endo-
omal compartments of the cell [24] the deglycosylated APP
s more likely to undergo amyloidogenic processing by - and
-secretase pathway. Recent studies have shown that glucocor-
icoid treatment of either mouse neuronal cells or the 3XTg-AD
ouse increases the formation of A [12]. This appears to be
ue to an increase in the expression levels of both APP and
-secretase. The formation of A peptide oligomers may also
isrupt cognitive function, even prior to nerve cell death [7]. The
ncrease in APPs within the hippocampus over the same period
s habituation to a repeated stressor could therefore represent
compensatory response in relatively young adult rats. Fur-
her studies will be required to determine the exact mechanisms
esponsible for the changes in APP processing and whether an
ge-induced impairment in this neuroadaptation increases the
isk of the stimulation of the AD-associated protein processing
athways.
cknowledgementsThis study was supported by funding from the University of
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